100 Recruiting Trials

Clinical Trials for Lupus

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

Showing 15 of 100 recruiting trials

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
PHASE1 Philadelphia, Pennsylvania NCT06839976
Recruiting
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
PHASE1 Houston, Texas +1 more NCT06434363
Recruiting
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
PHASE1 Bethesda, Maryland NCT07262983
Recruiting
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
PHASE1 Charleston, South Carolina NCT06737380
Recruiting
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
NA Phoenix, Arizona +4 more NCT05612750
Recruiting
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
NA Salt Lake City, Utah NCT07282392
Recruiting
Safety and Efficacy of ONT01 in Lupus
EARLY_PHASE1 New York, New York NCT07107659
Recruiting
The BRIDGE Pain Study
N/A Cincinnati, Ohio NCT07602595
Recruiting
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
N/A Lexington, Massachusetts NCT07128966
Recruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
N/A Delafield, Wisconsin NCT04806620
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
PHASE3 Upland, California +4 more NCT07355218
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
PHASE3 Los Angeles, California +4 more NCT07332481
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
PHASE3 Phoenix, Arizona +4 more NCT05835310
Recruiting
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
PHASE3 Orchard Park, New York +4 more NCT06711887
Recruiting
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3 Anniston, Alabama +4 more NCT07430306
Recruiting
See all 100 results
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Lupus Trials by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon